Phase
Condition
Covid-19
Treatment
Individual follow-ups
One day course
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Symptoms attributable to long COVID according to WHO definition [14] that affecttheir daily activities
Positive Covid test; a home-test, PCR test or serology.
Neurocognitive symptoms
Age between 18 and 65 years
Participant is able and willing to provide informed consent
Exclusion
Exclusion Criteria:
Patients that do not want to comply to planned physical study visits
Patients who are unable to complete surveys in Norwegian
Patients with known chronic neurocognitive disease before Covid-19 or other diseasesthat can explain current symptoms
Study Design
Connect with a study center
University hospital of North Norway
Tromsø, Troms 9038
NorwayActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.